Moderna on Tuesday said that its experimental Covid-19 vaccine has gained 'Fast Track' designation from the Food and Drug Administration (FDA). Moderna, which is working on a coronavirus vaccine candidate codenamed mRNA-1273, has completed the Phase 1 clinical study for the vaccine and has said it is preparing for the mid-stage trial.